Pulse Biosciences (PLSE) Profit After Tax (2015 - 2025)

Pulse Biosciences' Profit After Tax history runs 11 years deep, the most recent figure standing at -$19.4 million for Q3 2025.

• On a quarterly basis, Profit After Tax fell 52.88% year-over-year to -$19.4 million in Q3 2025; TTM through Sep 2025 was -$74.7 million, a 61.99% decrease from a year earlier, with the FY2025 full-year figure at $72.8 million, up 235.86% from the prior year.
• Profit After Tax declined to -$19.4 million in Q3 2025 per PLSE's latest filing, from -$19.2 million in the prior quarter.
• Across five years, Profit After Tax topped out at -$9.2 million in Q4 2022 and bottomed at -$19.4 million in Q4 2024.
• The 5-year median for Profit After Tax is -$14.3 million (2021), against an average of -$14.4 million.
• Across the five-year window, Profit After Tax soared 43.26% in 2023 and plunged 68.39% in 2025, its largest moves.
• Year by year, Profit After Tax stood at -$15.4 million in 2021, then surged by 40.34% to -$9.2 million in 2022, then retreated by 29.75% to -$11.9 million in 2023, then slumped by 62.45% to -$19.4 million in 2024, then changed by 0.0% to -$19.4 million in 2025.
• Per Business Quant, the three latest PLSE Profit After Tax figures stand at -$19.4 million (Q3 2025), -$19.2 million (Q2 2025), and -$16.8 million (Q1 2025).